TRAF6 and neoplasm: We examined E‐cadherin, vimentin, TRAF6 and p65 expression in the subcutaneous tumours by IHC and found that SNHG16 silencing increased E‐cadherin expression, decreased vimentin expression, decreased TRAF6 expression and decreased p65 nuclear signals and that these effects were partly abolished by miR‐605‐3p silencing (Figure 6C, D).